Save Ezetimibe For Patients Who Don't Tolerate High-Dose Statins

Controversy over the role of ezetimibe (Zetia, etc) and the pros and cons of aiming for LDL goals will heat up...again.

Ezetimibe fell out of favor several years ago...when a study showed that adding ezetimibe to simvastatin did NOT work better than simvastatin alone to slow atherosclerosis progression.

Now the big new "IMPROVE-IT" trial shows that adding ezetimibe to simvastatin 40 mg reduces CV events compared to simvastatin alone.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals